CN104762285B - 一种自内裂解大肠杆菌的裂解酶及其应用 - Google Patents
一种自内裂解大肠杆菌的裂解酶及其应用 Download PDFInfo
- Publication number
- CN104762285B CN104762285B CN201510197003.3A CN201510197003A CN104762285B CN 104762285 B CN104762285 B CN 104762285B CN 201510197003 A CN201510197003 A CN 201510197003A CN 104762285 B CN104762285 B CN 104762285B
- Authority
- CN
- China
- Prior art keywords
- clyn
- escherichia coli
- expression
- lyases
- cracking
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000588724 Escherichia coli Species 0.000 title claims abstract description 48
- 238000005336 cracking Methods 0.000 title claims abstract description 35
- 102000004317 Lyases Human genes 0.000 title claims abstract description 21
- 108090000856 Lyases Proteins 0.000 title claims abstract description 21
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 25
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 20
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 claims abstract description 17
- 230000003834 intracellular effect Effects 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims description 10
- MURGITYSBWUQTI-UHFFFAOYSA-N fluorescin Chemical compound OC(=O)C1=CC=CC=C1C1C2=CC=C(O)C=C2OC2=CC(O)=CC=C21 MURGITYSBWUQTI-UHFFFAOYSA-N 0.000 claims description 6
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 claims description 5
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 5
- 239000001963 growth medium Substances 0.000 claims description 5
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 5
- 239000013604 expression vector Substances 0.000 claims description 4
- 102000014150 Interferons Human genes 0.000 claims description 3
- 108010050904 Interferons Proteins 0.000 claims description 3
- 229940079322 interferon Drugs 0.000 claims description 3
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 claims description 2
- 239000002773 nucleotide Substances 0.000 claims description 2
- 229960005137 succinic acid Drugs 0.000 claims description 2
- 108091006146 Channels Proteins 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 241000894006 Bacteria Species 0.000 abstract description 16
- 108010048367 enhanced green fluorescent protein Proteins 0.000 abstract description 13
- 230000006698 induction Effects 0.000 abstract description 11
- 108090000790 Enzymes Proteins 0.000 abstract description 5
- 102000004190 Enzymes Human genes 0.000 abstract description 5
- 238000002525 ultrasonication Methods 0.000 abstract description 5
- 230000009089 cytolysis Effects 0.000 abstract description 4
- 239000013613 expression plasmid Substances 0.000 abstract description 3
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract description 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract description 2
- 229940088598 enzyme Drugs 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 229960000856 protein c Drugs 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 10
- 230000001580 bacterial effect Effects 0.000 description 6
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000012408 PCR amplification Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 description 2
- 241000209094 Oryza Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010074124 Escherichia coli Proteins Proteins 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000003670 luciferase enzyme activity assay Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000008823 permeabilization Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510197003.3A CN104762285B (zh) | 2015-04-23 | 2015-04-23 | 一种自内裂解大肠杆菌的裂解酶及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510197003.3A CN104762285B (zh) | 2015-04-23 | 2015-04-23 | 一种自内裂解大肠杆菌的裂解酶及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104762285A CN104762285A (zh) | 2015-07-08 |
CN104762285B true CN104762285B (zh) | 2017-10-27 |
Family
ID=53644377
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510197003.3A Active CN104762285B (zh) | 2015-04-23 | 2015-04-23 | 一种自内裂解大肠杆菌的裂解酶及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104762285B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111909918B (zh) * | 2019-05-10 | 2022-10-14 | 中国科学院微生物研究所 | 一种内溶素突变体及其编码基因与应用 |
JP7259131B2 (ja) | 2019-08-05 | 2023-04-17 | ワッカー ケミー アクチエンゲゼルシャフト | 発酵法で組換えタンパク質を放出する細菌株 |
CN110592057B (zh) * | 2019-09-27 | 2022-01-28 | 昆明理工大学 | 嵌合裂解酶ILTphg和编码此酶的多核苷酸 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011065854A1 (en) * | 2009-11-24 | 2011-06-03 | Technophage, Investigação E Desenvolvimento Em Biotecnologia, Sa | Enterococcal phage peptides and methods of use thereof |
CN102186878A (zh) * | 2008-08-19 | 2011-09-14 | 拜奥默里克斯公司 | 人工肽聚糖裂解酶和肽聚糖结合蛋白 |
CN102197132A (zh) * | 2008-08-26 | 2011-09-21 | 勒芬天主教大学,K.U.勒芬R&D | 抗微生物剂 |
CN103122347A (zh) * | 2013-02-01 | 2013-05-29 | 中国科学院武汉病毒研究所 | 一种杀灭葡萄球菌的裂解酶及其应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2984933C (en) * | 2008-07-03 | 2020-07-07 | The Rockefeller University | A chimeric bacteriophage lysin with activity against staphylococci bacteria |
-
2015
- 2015-04-23 CN CN201510197003.3A patent/CN104762285B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102186878A (zh) * | 2008-08-19 | 2011-09-14 | 拜奥默里克斯公司 | 人工肽聚糖裂解酶和肽聚糖结合蛋白 |
CN102197132A (zh) * | 2008-08-26 | 2011-09-21 | 勒芬天主教大学,K.U.勒芬R&D | 抗微生物剂 |
WO2011065854A1 (en) * | 2009-11-24 | 2011-06-03 | Technophage, Investigação E Desenvolvimento Em Biotecnologia, Sa | Enterococcal phage peptides and methods of use thereof |
CN103122347A (zh) * | 2013-02-01 | 2013-05-29 | 中国科学院武汉病毒研究所 | 一种杀灭葡萄球菌的裂解酶及其应用 |
Non-Patent Citations (9)
Title |
---|
Analysis of the catalytic domain of the lysin of the lactococcal bacteriophage Tuc2009 by chimeric gene assembling;Sheehan M. M.等;《FEMS MICROBIOLOGY LETTERS》;19960615;第140卷(第1期);第23-28页 * |
Cloning, molecular characterization, and expression of the genes encoding the lytic functions of actococcal bacteriophage ΦLC3: a dual lysis system of modular design;N. K. Birkeland;《Canadian Journal of Mocrobiology》;19940831;第40卷(第8期);摘要,第662页右栏最后一段 * |
Functional analysis of antibacterial activity of Bacillus amyloliquefaciens phage endolysin against Gram-negative bacteria;M. Morita等;《FEBS Letters》;20010614;第500卷(第1-2期);第56-59页 * |
Molecular Characterization of Lactococcal Bacteriophage Tuc2009 and Identification and Analysis of Genes Encoding Lysin,a Putative Holin,a Putative Holin,and Two Structural Proteins;E. K. Arendt等;《APPLIED AND ENVIRONMENTAL MICROBIOLOGY》;19940630;第60卷(第6期);第1875-1883页 * |
Novel Chimeric Lysin with High-Level Antimicrobial Activity against Methicillin-Resistant Staphylococcus aureus In Vitro and In Vivo;H. Yang等;《ANTIMICROBIAL AGENTS AND CHEMOTHERAPY》;20140131;第58卷(第1期);摘要 * |
登录号:AAA20878.1;Birkeland N. K.等;《GenBank》;20040322;第331-429位 * |
登录号:AAK19881.1;Van Sinderen D.等;《GenBank》;20010315;第310-428位 * |
登录号:AIZ92304.1;Berlin K.等;《GenBank》;20141215;第1-165位 * |
登录号:CP009685.1;Berlin K.等;《GenBank》;20141215;第3117349-3117846位 * |
Also Published As
Publication number | Publication date |
---|---|
CN104762285A (zh) | 2015-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI408228B (zh) | 用於生產一標的蛋白質的核酸建構物、重組型載體以及方法 | |
CN103031327A (zh) | 原核细菌光诱导基因表达***及其调控基因表达的方法 | |
CN104762285B (zh) | 一种自内裂解大肠杆菌的裂解酶及其应用 | |
CN108913813A (zh) | 用于鉴别DAdV-2和DAdV-3的引物组 | |
CN102559709B (zh) | 一种来自恶臭假单胞菌的黄素单加氧酶基因fmo及其制备方法和应用 | |
CN106947766A (zh) | 一种枯草芽孢杆菌具有启动子功能的dna片段及其应用 | |
CN105802985A (zh) | 一种快速实现地衣芽孢杆菌基因敲除的方法 | |
CN107164395A (zh) | 一种藻毒素降解菌的分子标记、藻毒素降解菌及藻毒素降解菌的制备方法 | |
CN104031913B (zh) | 一种用于在枯草芽孢杆菌中分泌表达外源蛋白的表达设备 | |
CN114807196B (zh) | 一种追踪土传植物致病菌传播耐药基因的荧光标记方法 | |
CN103665126B (zh) | 橡胶树来源的HbsHsp2蛋白及其编码基因与应用 | |
CN108251546A (zh) | 一种植物乳杆菌内源性信号肽的预测方法及其应用 | |
CN107142273A (zh) | 一种利用磁感应蛋白作为纯化标签实现外源蛋白一步纯化与固定化的方法,应用及通用载体 | |
CN106591347B (zh) | 一种包含噬菌体溶菌酶的表达***及其运用 | |
CN108034642A (zh) | 葡萄糖氧化酶CnGOD19及其改良酶、基因和应用 | |
CN105861533A (zh) | 一种通过镁离子诱导大肠杆菌裂解的重组载体及应用 | |
CN105695472B (zh) | 一种枯草芽孢杆菌发酵生产启动子及其应用方法 | |
CN106318925B (zh) | 利用枯草芽孢杆菌高效表达pi-plc基因的方法 | |
CN105462906A (zh) | 可定植动物肠道的荧光标记大肠杆菌及其制备方法 | |
CN103849640B (zh) | 一种寡核苷酸和可消除质粒共转化用于大肠杆菌必需基因点突变的方法 | |
CN107119051A (zh) | 一种巨大芽孢杆菌具有启动子功能的dna片段及其应用 | |
CN116769814B (zh) | 一种大肠杆菌益生菌t7表达***及其应用 | |
CN105779500A (zh) | 一种提高重组杆状病毒表面展示效率的方法 | |
RU2542486C1 (ru) | ШТАММ БАКТЕРИИ Esherichia coli EX pQE30, ПРОДУЦЕНТ ЭНДОКСИЛАНАЗЫ БАКТЕРИИ Geobacillus stearothermophillus 22 | |
CN106754980A (zh) | Pcv2型衣壳蛋白基因、表达菌株及可溶性表达方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
DD01 | Delivery of document by public notice |
Addressee: Wuhan Faye Gile C biological science and Technology Co.,Ltd. Office Document name: Notification that Application Deemed not to be Proposed |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160405 Address after: 430075 A7 Exhibition Center of biomedicine Park, 858 hi tech Avenue, East Lake New Technology Development Zone, Wuhan, Hubei Applicant after: WUHAN PHAGELUX BIO-TECH Co.,Ltd. Address before: 430075, B7 building, Optics Valley biological city, 666 hi tech Avenue, Wuhan, Hubei, Wuhan Applicant before: Wuhan Phagelux Bio-tech Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201125 Address after: Co services Cayman limited, P.O. Box 10008 willow house, cricket square, Grand Cayman Islands Patentee after: Figelok Co.,Ltd. Address before: 430075 A7 Exhibition Center of biomedicine Park, 858 hi tech Avenue, East Lake New Technology Development Zone, Wuhan, Hubei Patentee before: Wuhan Phagelux Bio-tech Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231020 Address after: Room 201, 1012 College Road, Dover, Delaware, United States Patentee after: Targeted Antibiotics Biopharmaceutical Technology Co.,Ltd. Address before: Co services Cayman limited, P.O. Box 10008 willow house, cricket square, Grand Cayman Islands Patentee before: Figelok Co.,Ltd. |